Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Biotec Markets - How Is a Silence Managing the Down Turn?
The company has been muddling through biotec markets, that down turn, if you will. We're a model that actually draws from two sides, a partnerships and from our own a development pipe point. So because we have large partnerships with great companies like astro senica, we're allowed to develop some of their projects and gain non delutive money for those projects.
Transcript
Play full episode
